Factors Associated with Ordering Laboratory Monitoring of High-Risk Medications
Knowledge about factors associated with provider ordering of appropriate testing is limited.
To determine physician factors associated with ordering recommended laboratory monitoring tests for high-risk medications.
Retrospective cohort study of patients prescribed a high-risk medication requiring laboratory monitoring in a large multispecialty group practice between 1 January 2008 and 31 December 2008. Analyses are based on administrative claims and electronic medical records. The outcome is a physician order for each recommended laboratory test for each prescribed medication. Key predictor variables are physician characteristics, including age, gender, specialty training, years since completing training, and prescribing volume. Additional variables are patient characteristics such as age, gender, comorbidity burden, whether the medication requiring monitoring is new or chronic, and drug-test characteristics such as inclusion in black box warnings. We used multivariable logistic regression, accounting for clustering of drugs within patients and patients within providers.
Physician orders for laboratory testing varied across drug-test pairs and ranged from 9 % (Primidone–Phenobarbital level) to 97 % (Azathioprine–CBC), with half of the drug-test pairs in the 85-91 % ordered range. Test ordering was associated with higher provider prescribing volume for study drugs and specialist status (primary care providers were less likely to order tests than specialists). Patients with higher comorbidity burden and older patients were more likely to have appropriate tests ordered. Drug-test combinations with black box warnings were more likely to have tests ordered.
Interventions to improve laboratory monitoring should focus on areas with the greatest potential for improvement: providers with lower frequencies of prescribing medications with monitoring recommendations and those prescribing these medications for healthier and younger patients; patients with less interaction with the health care system are at particular risk of not having tests ordered. Black box warnings were associated with higher ordering rates and may be a tool to increase appropriate test ordering.
KEY WORDSlaboratory monitoring high-risk medications ambulatory
- 1.Institute of Medicine. To Err is Human: Building a Safer Health System. 2000.Google Scholar
- 21.Yu DT, Seger DL, Lasser KE, et al. Impact of implementing alerts about medication black-box warnings in electronic health records. Pharmacoepidemiol Drug Saf. Dec 28 2010.Google Scholar
- 22.UpToDate. 2010; Available at: http://www.uptodate.com. Accessed May 15, 2014.
- 23.Micromedex® Healthcare Series. Thomson Reuters (Healthcare) Inc; 2010. http://www.micromedex.com. Accessed May 15, 2014.
- 24.Pharmacist’s Letter. Therapetic Research Center; 2010. http://pharmacistsletter.therapeuticresearch.com. Accessed May 15, 2014.
- 25.Physicians’ Desk Reference. Thomson Corporation; 2010. http://www.pdr.net. Accessed May 15, 2014.
- 26.Rogers WH. Regression standard errors in clustered samples. Stata Technical Bulletin. 1993;13:19–23.Google Scholar
- 28.Wooldridge JM. Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press; 2002.Google Scholar
- 30.Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis: Springer Verlag; 2001.Google Scholar
- 33.van Luin M, Wit FW, Smit C, et al. Adherence to HIV Therapeutic Drug Monitoring Guidelines in The Netherlands. Ther Drug Monit. Dec 29.Google Scholar